Avrobio SG&A Expense (Quarterly) Trends

Avrobio Inc (DELISTED) (AVRO:DL)

16.80 -0.24 (-1.41%) USD | NASDAQ | Jun 20, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	7.258M
December 31, 2023	5.237M
September 30, 2023	6.262M
June 30, 2023	4.581M
March 31, 2023	7.887M
December 31, 2022	7.12M
September 30, 2022	7.066M
June 30, 2022	8.897M
March 31, 2022	10.16M
December 31, 2021	8.962M
September 30, 2021	9.577M
June 30, 2021	8.831M
March 31, 2021	8.357M
December 31, 2020	8.477M
September 30, 2020	8.209M

Date	Value
June 30, 2020	7.991M
March 31, 2020	8.315M
December 31, 2019	6.214M
September 30, 2019	5.022M
June 30, 2019	4.345M
March 31, 2019	5.254M
December 31, 2018	3.867M
September 30, 2018	3.00M
June 30, 2018	2.14M
March 31, 2018	2.141M
December 31, 2017	0.965M
September 30, 2017	0.959M
June 30, 2017	0.661M
March 31, 2017	0.61M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.581M

Minimum

Jun 2023

10.16M

Maximum

Mar 2022

7.602M

Average

7.991M

Median

Jun 2020

SG&A Expense (Quarterly) Benchmarks